The drug is intended for use in the oral cavity and can be administered only in tissues in which there is no inflammation. Do not inject into inflamed tissues.
When performing preliminary procedures and anesthesia, a constant verbal contact of the dentist with the patient is required (questioning the patient, clarifying the questions that appear as the patient complains of complaints and sensations).
To prevent intravascular injection, an aspirate test (sample) is performed: before injecting the drug solution, the syringe piston must be pulled by itself. With a positive aspiration sample, you need to pull the needle, then re-push it forward.The injection pressure should correspond to the sensitivity of the tissue.
When applying the drug for the first time, a skin test is performed: 0.02 ml of drug is intradermally injected and the local reaction is observed for 15 minutes. In the presence of severe hyperemia, pruritus and other intolerance, the use of the drug in this patient is contraindicated.
With uncomplicated removal of the upper jaw teeth in the absence of inflammation, it is usually sufficient to create the Artifrin forte depot in the region of the transitional fold by inserting it into the submucosa from the vestibular side 1.7 ml per each tooth. In rare cases, in order to achieve complete anesthesia, additional administration of 1 to 1.7 ml of the drug may be required. In most cases this allows you not to carry a painful palatine injection.
With incisions and suturing in the palate with the goal of creating a palatine depot, about 0.1 ml of the drug for each injection is needed.
If you remove the premolars of the lower jaw in the absence of inflammation, you can avoid mandibular anesthesia, since infiltration anesthesia provided by injection of 1.7 ml per tooth is usually sufficient.If this is not the way to achieve the desired effect, an additional injection of 1-1.7 ml of the drug into the submucosa should be performed in the region of the transitional fold of the lower jaw from the vestibular side. If, however, in this case, it was not possible to achieve complete anesthesia, it is necessary to conduct a conductive blockade of the mandibular nerve.
To prepare the cavity and prepare the teeth for the crowns, it is enough to inject 0.5 to 1.7 ml of the drug per tooth for the oral mucosa.
During surgical interventions, Artifrin forte dosages individually depending on the severity and duration of the intervention. When performing one treatment procedure, adults can administer up to 7 mg of articaine per 1 kg of body weight. In clinical studies, patients well tolerated doses up to 500 mg (corresponding to 12.5 ml of the drug).
Children older than 4 years of the drug is administered in doses, depending on the age, body weight and method of anesthesia. For children with a body weight of 20-30 kg, a dose of 0.25 ml to 1 ml is sufficient, for children with a body weight of 30-45 kg, from 0.5 ml to 2 ml. For children aged 4 to 12 years, the dose of the drug administered should not exceed 5 mg of articaine per 1 kg of body weight.
In elderly patients and / or patients with severe and renal insufficiency, it is possible to create increased plasma concentrations of articaine, so these patients should be treated minimum doses necessary to achieve sufficient depth of anesthesia.